Consensus Transgene

Stocks

TNG

FR0005175080

Biotechnology & Medical Research

Real-time Euronext Paris Other stock markets 12:01:59 03/07/2026 +04			5-day change	1st Jan Change
0.7300 ^EUR	+0.41%		-0.14%	-23.96%

06-29	Transgene SA - Special Call
06-25	Oddo BHF Stays Positive on Transgene

Evolution of the Average Target: Transgene

Evolution of the Target Price: Transgene

Changes in Analyst Recommendations: Transgene

fc.gdAxub5Tn54U-XYSeAB7Ld_-wnswouGYsBqecfke0Ps.-IJ48tsi0sdcnDBNMmgXG6mYujZD9Ljd3y3bSctptbH5vmSB0wbT01izRg~ee727608ab0248eeca689befce5b943b

Analysts' recommendations: Transgene

06-25	Oddo BHF Stays Positive on Transgene
04-07	Transgene stands out following licensing agreement with NEC Bio
11-27	Oddo BHF Lowers Target Price on Transgene but Remains Upbeat
13/10/25	Transgene and BioInvent International AB Jointly Present a Poster on Transational Data and Updated Clinical Results from the Phase I Study of BT-001	CI
18/09/25	Transgene: analysts reiterate their recommendations after results
17/09/25	The day the Fed resumed its rate cuts
06/11/24	Transgene: Invest Securities remains Buy
15/10/24	Transgene: Invest Securities confirms its Buy recommendation
26/09/24	Transgene: Invest Securities confirms its opinion
06/06/23	Transgene: Invest Securities confirms its Buy rating
05/06/23	Transgene: Invest Securities reiterates its recommendation
22/03/23	Transgene: Invest Securities reduces its target
10/01/23	Transgene: Invest Securities confirms its Buy rating

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	TRANSGENE			-	-	+51.31%
	ARGENX SE					+6.06%
	WUXI APPTEC CO., LTD.					+20.74%
	BIONTECH SE					+26.98%
	INSMED INCORPORATED					+76.57%
	WUXI BIOLOGICS (CAYMAN) INC.					+30.35%
	GENMAB A/S					+23.43%
	PHARMAESSENTIA CORPORATION					-26.02%
	EXELIXIS, INC.					-10.36%
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.					+17.12%
	Average					+21.62%
	Weighted average by Cap.					+19.21%

See all sector consensus

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.7270EUR

Average target price

1.100EUR

Spread / Average Target

+51.31%

High Price Target

1.100EUR

Spread / Highest target

+51.31%

Low Price Target

1.100EUR

Spread / Lowest Target

+51.31%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.7270EUR

Average target price

1.100EUR

Spread / Average Target

+51.31%

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Stock Market
Stocks
TNG Stock
Consensus Transgene

As early as today, start finding the best investment opportunities!